恒申集团参股的 浙江锦华新材料股份有限公司（以下简称"锦华新材"）近日 在北京证券交易所成功挂牌上市。这是恒申集团今年内投资培育的第 二家上市企业。 据了解，锦华新材自2007年成立以来，专注于酮肟系列精细化学品的研发、生产和销售，主要产品涵盖硅烷交联剂、羟胺盐、甲氧胺盐酸盐、乙醛 肟等，已与拜耳、万华化学等国内外知名企业建立长期稳定的合作关系。作为国内硅烷交联剂、羟胺盐细分领域的龙头企业，该公司首创"肟-肟基 硅烷-羟胺盐"绿色循环产业链，实现资源高效利用和生产过程清洁化的有机统一。此次上市，锦华新材募集资金净额达5.49亿元，将用于高端偶联 剂项目、中试项目及智能工厂建设等领域，进一步强化技术与产能优势。 恒申集团化工板块全球制造中心总经理谷俊表示："锦华新材成功上市，不仅是其自身发展史上的重要事件，更是恒申集团围绕产业链和领先的技 术优势，开展精准投资、推动产业协同战略的又一成功实践。"未来，恒申集团将继续以资本合作为纽带，依托自身产业链资源整合能力，助力锦 华新材充分发挥技术和管理优势，加快打造全球最大酮肟产业基地，共同推动精细化工产业高质量发展。 来源 / 恒申集团 编辑 / 王丹阳 审核/ 同黎娜 ...

锦华新材主要从事酮肟系列精细化学品的研发、生产和销售，主要产品包括硅烷交联剂、羟胺盐、甲氧胺盐酸盐、乙醛肟等。 中国经济网北京9月25日讯 今日，浙江锦华新材料股份有限公司（证券简称：锦华新材，证券代码：920015.BJ）在北交所上市。该股开盘报39.00 元，截至收盘报42.29元，涨幅133.00%，成交额11.32亿元，振幅71.46%，换手率91.23%，总市值55.26亿元。 本次发行前，巨化集团有限公司（以下简称"巨化集团"）直接持有公司80,837,240股股份，持股比例为82.49%，为公司控股股东。浙江省国资委直接 持有公司控股股东巨化集团76.49%股份，通过杭州钢铁集团有限公司间接持有巨化集团13.51%股权，共计持有巨化集团90.00%股权。公司的实际控制人 为浙江省国资委。 本次发行后，巨化集团持有公司的股份数量不变，为80,837,240股，占本次发行前公司总股本的82.49%，占本次发行后超额配售选择权行使前公司总 股本的61.87%，占本次发行后超额配售选择权全额行使后公司总股本的59.63%。报告期内及本次发行前后，公司控股股东、实际控制人未发生变动。 锦华新材于2025年 ...

Core Viewpoint - The ChiNext Index experienced a significant rise, surpassing 3200 points, with leading stock CATL's share price exceeding 400 yuan and its market capitalization exceeding 1.8 trillion yuan, surpassing Kweichow Moutai [1][3]. Market Performance - The A-share market showed divergence, with the Shanghai Composite Index and Northbound 50 Index performing relatively weakly, while the ChiNext Index and Sci-Tech 50 Index showed strong performance. As of noon, the Shanghai Composite Index rose by 0.16%, the Shenzhen Component Index increased by 1.14%, and the ChiNext Index surged by 2.22% [3]. - The ChiNext Index reached a peak intraday increase of 2.5%, marking a new high for the period [3]. Key Stocks - Among the ChiNext Index constituents, CATL's stock price reached a peak of 402.59 yuan, with a total market value of over 1.8 trillion yuan, surpassing Kweichow Moutai [1][3]. - Other notable stocks included Kunlun Wanwei, which surged by 10.22%, and Dingsheng Technology, which rose by 8.71% [3]. Sector Performance - In terms of industry sectors, Media, Electric Equipment, Nonferrous Metals, Computers, and Communications sectors showed the highest gains, while Transportation, Agriculture, Coal, and Textile sectors performed weakly [5]. New Stocks - New stock Weichuang New Materials saw a consecutive two-day limit up of 20%, with a year-to-date increase of nearly 1900%. The company announced a planned acquisition of 37% of its shares at a price of 7.78 yuan per share, requiring a maximum total funding of 1.161 billion yuan [6]. - New stock Jianfa Zhixin experienced an intraday increase of over 500%. The company operates as a national high-value medical device distributor [8]. - New stock United Power saw an intraday increase of over 190%. The company focuses on becoming a leading provider of intelligent electric vehicle components and solutions [9]. - New stock Jinhua New Materials experienced an intraday increase of over 160%. The company specializes in the research, production, and sales of ketoxime series fine chemicals [10]. Hong Kong Market - The Hang Seng Tech Index showed a strong performance, rising approximately 2% during the morning session, with notable gains from stocks like Huahong Semiconductor and JD Group, both exceeding 6% [12][13].

Group 1: Market Performance - The ChiNext Index experienced a significant increase, surpassing 3200 points and reaching a new high [1][3] - The index rose by 2.22% at midday, while the Shanghai Composite Index increased by 0.16% and the Shenzhen Component Index rose by 1.14% [2] - Among the ChiNext constituents, Ningde Times' stock price exceeded 400 yuan, with a total market capitalization surpassing 1.8 trillion yuan, overtaking Kweichow Moutai [1][3] Group 2: Notable Stocks - Kunlun Wanwei saw a substantial increase of 10.22%, and Dingsheng Technology rose by 8.71% [5] - Other notable stocks included Upwind New Materials, which experienced a continuous 20% limit-up for two trading days, with a year-to-date increase of nearly 1900% [5] - Upwind New Materials announced a planned acquisition by Shanghai Zhiyuan Hengyue Technology Partnership, aiming to acquire 37% of the company's shares at a price of 7.78 yuan per share, with a maximum total funding requirement of 1.161 billion yuan [5] Group 3: New Stocks Performance - Three new stocks listed today, all experiencing significant gains [7] - Jianfa Zhixin's stock price surged over 500%, focusing on high-value medical device distribution and providing centralized operation services for medical consumables [8] - United Power's stock price increased by over 190%, specializing in intelligent electric vehicle components and solutions [9] - Jinhua New Materials saw its stock price rise by over 160%, focusing on the research, production, and sales of ketoxime series fine chemicals [10] Group 4: Hong Kong Market - The Hang Seng Tech Index showed a strong performance, rising approximately 2% [11] - Key constituents such as Huahong Semiconductor and JD Group saw their stock prices increase by over 6% [11]

Core Viewpoint - The recent listings of Jianfa Zhixin, United Power, and Jinhua New Materials on the stock exchanges highlight the growth and investment opportunities in the medical device and new energy sectors in China [1][2]. Group 1: Jianfa Zhixin - Jianfa Zhixin is a national high-value medical device distributor, primarily engaged in direct sales and distribution, providing centralized operation services for medical consumables to hospitals [1]. - The company has a market capitalization of 2.97 billion yuan, with an issuance price of 7.05 yuan per share and a P/E ratio of 13.29, significantly lower than the industry average of 25.73 [2]. - In 2024, Jianfa Zhixin's revenue is projected to be divided into three segments: direct sales (11.03 billion yuan, 61.69%), distribution (6.74 billion yuan, 37.68%), and services (112 million yuan, 0.63%) [4]. - The company plans to invest 1.4 billion yuan in information system upgrades, 1.04 billion yuan in centralized operation services, and 2.4 billion yuan to supplement working capital [3]. Group 2: United Power - United Power, spun off from the industrial automation giant Inovance Technology, specializes in new energy vehicle power systems, including electric drive and power supply systems [6][7]. - The company is a leader in the new energy vehicle power system sector, providing solutions to over 40 vehicle manufacturers and participating in the entire lifecycle of vehicle design and production [7]. - United Power's accounts receivable have increased significantly, with values of 1.85 billion yuan, 3.61 billion yuan, and 5.68 billion yuan from 2022 to 2024, representing 20.37%, 29.38%, and 31.45% of total assets respectively [8]. Group 3: Jinhua New Materials - Jinhua New Materials focuses on the research, production, and sales of ketoxime series fine chemicals, being a leader in the domestic silane crosslinking agent market with market shares of 27.85%, 31.60%, and 38.16% from 2022 to 2024 [9]. - The company's products are essential for various industries, including construction, energy, electronics, and new energy vehicles [9]. - Jinhua New Materials has received multiple national honors and has participated in the formulation of several industry standards [9].

9月25日新股上市 (共3只) | 业务及亮点 | I ！ い不ビい | | --- | --- | | | 企业、超过170个车型提供动力系统解决方案。 | | | 3、公司是我国业内最早布局海外市场、实现向国 | | | 自主品牌之一，公司海外市场收入呈现较快增长， | | | 至2024年的7.69亿元。 | | | 锦华新材(北交所,92001 | | 发行价格 | 18.15元 | | 留答率 | 0.066173% 询价 | | 总市值 | | | 发行市盈率 | 11.52 行】 | | | 1、公司主要产品为硅烷交联剂、羟胺盐、甲氧膀 | | 业务及亮点 | 2、公司为国内硅烷交联剂细分领域的龙头企业， | | | 与消费国。 | 建发致新(创业板,30158 *免责声明：文章内容仅供参考，不构成投资建议 | | A CARATI VELLIK) O | | | --- | --- | --- | | 发行价格 | 7.05元 | | | 中签率 | 0.019847% | 询价 | | 总市值 | 29.70亿 | | | 发行市盈率 | 13.29 | 行业 | | 1、 业务及亮点 | ...

Group 1: Company Overview - Jianfa Zhixin is a national high-value medical device distributor, primarily engaged in direct sales and distribution of medical devices, providing centralized operation services for medical consumables to hospitals [1][3] - The company is a subsidiary of Xiamen Jianfa Group, with the Xiamen State-owned Assets Supervision and Administration Commission indirectly holding 51.02% of Jianfa Zhixin's shares [3][4] - In 2024, Jianfa Zhixin's revenue is projected to be divided into three main segments: direct sales (11.03 billion, 61.69%), distribution (6.74 billion, 37.68%), and service (112 million, 0.63%) [3][4] Group 2: Financial Metrics - Jianfa Zhixin's asset-liability ratios from 2022 to 2024 are 87.39%, 87.19%, and 86.45%, indicating a high level of debt [5] - The company's liquidity ratios are relatively low, with current ratios of 1.13, 1.12, and 1.12, and quick ratios of 0.90, 0.86, and 0.81 over the same period [5] Group 3: Market Position and Clients - Jianfa Zhixin serves over 3,300 medical institutions across 31 provinces, providing a wide range of products from various well-known manufacturers [4] - The company is positioned as a leader in the high-value interventional device distribution sector, collaborating with major clients such as Beijing Anzhen Hospital and Jilin University First Hospital [4] Group 4: Joint Power Company Overview - United Power, established in 2016, is a spinoff from the A-share giant Huichuan Technology, focusing on providing power systems for new energy vehicles [5][10] - The company is a leader in the new energy vehicle power system sector, participating in over 20 national standard formulations and key R&D projects [10] Group 5: Financial Metrics and Risks - United Power's accounts receivable from 2022 to 2024 are projected to be 1.85 billion, 3.61 billion, and 5.68 billion, representing 20.37%, 29.38%, and 31.45% of total assets respectively [11] - The company has a significant customer base, including over 40 vehicle manufacturers, with a projected output of over 4.5 million power system products in 2024 [10] Group 6: Jin Hua New Material Overview - Jin Hua New Material specializes in the research, production, and sales of ketoxime series fine chemicals, being a leader in the silane crosslinking agent and hydroxylamine salt sectors [12][14] - The company's silane crosslinking agent products have a domestic market share of 27.85%, 31.60%, and 38.16% from 2022 to 2024 [14][15] Group 7: Financial Metrics and Market Risks - Jin Hua New Material plans to invest 5.07 billion (85.74%) in a high-end coupling agent project, with additional funds allocated for R&D and operational support [14] - The company faces potential risks from market demand fluctuations in downstream industries, particularly in real estate and photovoltaic sectors [16]

新 股 研 究 北证 50 指数震荡调整，北交所日均成交 金额回落至 300 亿元以下 ——北交所周报（2025 年 9 月第 3 周） 本报告导读： 9 月第 3 周沪深两市交易活跃度回升而北证交易活跃度有所下降，日均成交金额回 落至 300 亿元以下，北证 50 指数自前一周创历史新高后当周有所调整。当周北交所 2 只股票招股，1 只新股上市。 投资要点： 新股研究 /[Table_Date] 2025.09.23 | [Table_Authors] | | | --- | --- | | | 王政之(分析师) | | | 021-38674944 | | | wangzhengzhi@gtht.com | | 登记编号 | S0880517060002 | | | 施怡昀(分析师) | | | 021-38032690 | | | shiyiyun@gtht.com | | 登记编号 | S0880522060002 | | | 王思琪(分析师) | | | 021-38038671 | | | wangsiqi3@gtht.com | | 登记编号 | S0880524080007 | [Table_ ...

Core Viewpoint - Jinhua New Materials is set to be listed on the Beijing Stock Exchange with an IPO price of 18.15 CNY per share, aiming to raise 63.105 million CNY for various projects, including a high-end coupling agent project that will significantly increase production capacity [2][4]. Project Summaries - The IPO will raise funds for three main projects: - 60kt/a high-end coupling agent project with an investment of 50689.75 thousand CNY, which will add 30,000 tons/year of silane coupling agent capacity and 30,000 tons/year of functional silane intermediate capacity [2][3]. - 500 tons/year JH-2 pilot project with an investment of 3058.18 thousand CNY, aimed at developing hydroxylamine aqueous solution for use in chip manufacturing and special fiber production [2][3]. - Ketoxime industry chain smart factory construction project with an investment of 6310.50 thousand CNY [2][3]. Company Overview - Jinhua New Materials, established in December 2007, is a leading domestic enterprise in silane crosslinking agents and hydroxylamine salts, recognized as a national-level "little giant" enterprise [4]. - The company is state-owned, with the chemical giant Juhua Group as the largest shareholder, holding 82.49% of the shares [4]. - Major clients include Bayer, Bruntag, and several listed companies such as Wanhua Chemical and Xin'an Chemical [4]. Financial Performance - Projected revenues for Jinhua New Materials from 2022 to 2025 are as follows: - 2022: 994 million CNY - 2023: 1.115 billion CNY - 2024: 1.239 billion CNY - 2025: 1.063 billion CNY (a decrease of 14.25% year-on-year) [4]. - Net profits for the same period are projected as: - 2022: 79.592 million CNY - 2023: 173 million CNY - 2024: 211 million CNY - 2025: 199 million CNY (a decrease of 5.47% year-on-year) [4]. Market Position - Silane crosslinking agents are expected to generate 714 million CNY in revenue in 2024, accounting for 57.9% of total revenue, with a domestic market share of 38.16% [5]. - Hydroxylamine salts are projected to bring in 368 million CNY in revenue in 2024, representing 30% of total revenue, with a domestic market share of 42.37% [5]. - The company has a competitive position in the hydroxylamine salt market, with significant production capacity compared to other domestic players [5].

来源|贝多商业&贝多财经 本次上市，锦华新材拟将募投资金用于新增硅烷偶联剂和功能性硅烷中间体、羟胺水溶液等新产品，主要应用于复合材料、塑料、涂料和金属表面处理及建 筑防水材料、橡胶、芯片、特种纤维等领域。 天眼查App信息显示，锦华新材成立于2007年12月，前称为衢州锦华化工有限公司。目前，该公司的注册资本额为9800万元，法定代表人为雷俊，主要股东 包括巨化集团、丽水锦泓企业管理合伙企业（有限合伙）等。 | 大原台 | | 都在用的商业查询工具 | 查公司 查老板 音关系 查风险 | | | | --- | --- | --- | --- | --- | --- | | | | 国家中小企业发展子基金旗下机构 | 浙江锦华新材料股份有限公司 | 8 天眼一下 | | | 基本信息 109 | | 上市信息 439 | 法律诉讼 经营风险3 | 经营信息 999+ | 公司发 | | 主要股东 2 ● 品股权结构 | | | | | | | 最新公示4 | 工商量记6 | MP 历史主要股东4 | Alp 股权变更历程8 2 | | 更新日期(2: | | 序号 | | | 股东名称 | 股份类型 | 持股 ...